down arrow

Eiko Lifescience

  • Market Cap: Micro Cap
  • Industry: Finance/NBFC
  • ISIN: INE666Q01016
  • NSEID:
  • BSEID: 540204
INR
50.69
1.39 (2.82%)
BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 692

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

692 (-92.46%) Volume

Shareholding (Jan 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

31.27%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 3.79%

 
2

Flat results in Dec 24

 
3

Stock is technically in a Bearish range

4

With ROE of 2.3, it has a Expensive valuation with a 1.2 Price to Book Value

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Finance/NBFC

stock-summary
Market cap

INR 63 Cr (Micro Cap)

stock-summary
P/E

53.00

stock-summary
Industry P/E

20

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

2.27%

stock-summary
Price to Book

1.21

Revenue and Profits (1 Year):
Net Sales:
7 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-28.31%
0%
-28.31%
1 Year
-10.73%
0%
-10.73%
2 Years
-37.08%
0%
-37.08%
3 Years
10.44%
0%
10.44%
4 Years
-32.91%
0%
-32.91%
5 Years
468.27%
0%
468.27%

Latest dividend: 0.2 per share ex-dividend date: Sep-20-2017

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
102.85%
EBIT Growth (5y)
19.63%
Net Debt to Equity (avg)
0
Institutional Holding
0
ROE (avg)
3.79%
Valuation key factors
Factor
Value
P/E Ratio
53
Industry P/E
20
Price to Book Value
1.21
EV to EBIT
45.31
EV to EBITDA
27.92
EV to Capital Employed
1.29
EV to Sales
1.42
PEG Ratio
7.97
Dividend Yield
NA
ROCE (Latest)
2.84%
ROE (Latest)
2.27%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jan 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Lenus Finvest Private Limited (17.01%)

Highest Public shareholder

2b Black Bio Llp (14.79%)

Individual Investors Holdings

44.82%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 4.54% vs 50.91% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 16.67% vs -4.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.91",
          "val2": "6.61",
          "chgp": "4.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.45",
          "val2": "0.46",
          "chgp": "-2.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.02",
          "val2": "0.03",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.28",
          "val2": "0.24",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.51%",
          "val2": "6.96%",
          "chgp": "-0.45%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.91",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.82",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.06",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.65",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.34%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "26.40",
          "val2": "12.15",
          "chgp": "117.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.46",
          "val2": "0.38",
          "chgp": "284.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.14",
          "chgp": "-35.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.06",
          "val2": "0.38",
          "chgp": "178.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.53%",
          "val2": "3.13%",
          "chgp": "2.40%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 52.46% vs -27.90% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -2.60% vs 8.45% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "27.93",
          "val2": "18.32",
          "chgp": "52.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.61",
          "val2": "0.95",
          "chgp": "69.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.14",
          "val2": "0.15",
          "chgp": "-6.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.75",
          "val2": "0.77",
          "chgp": "-2.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.76%",
          "val2": "5.19%",
          "chgp": "0.57%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
6.91
6.61
4.54%
Operating Profit (PBDIT) excl Other Income
0.45
0.46
-2.17%
Interest
0.02
0.03
-33.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.28
0.24
16.67%
Operating Profit Margin (Excl OI)
6.51%
6.96%
-0.45%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 4.54% vs 50.91% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 16.67% vs -4.00% in Dec 2023

Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Change(%)
Net Sales
18.91
NA
NA
Operating Profit (PBDIT) excl Other Income
0.82
NA
NA
Interest
0.06
NA
NA
Exceptional Items
0.00
NA
NA
Consolidate Net Profit
0.65
NA
NA
Operating Profit Margin (Excl OI)
4.34%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Jun'24
Change(%)
Net Sales
26.40
12.15
117.28%
Operating Profit (PBDIT) excl Other Income
1.46
0.38
284.21%
Interest
0.09
0.14
-35.71%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.06
0.38
178.95%
Operating Profit Margin (Excl OI)
5.53%
3.13%
2.40%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
27.93
18.32
52.46%
Operating Profit (PBDIT) excl Other Income
1.61
0.95
69.47%
Interest
0.14
0.15
-6.67%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.75
0.77
-2.60%
Operating Profit Margin (Excl OI)
5.76%
5.19%
0.57%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 52.46% vs -27.90% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -2.60% vs 8.45% in Mar 2023

stock-summaryCompany CV
About Eiko Lifesciences Ltd stock-summary
stock-summary
Eiko Lifesciences Ltd
Micro Cap
Finance/NBFC
Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited. Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021. Earlier, the Company engaged in sale and purchase of shares and securities. At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally.
Company Coordinates stock-summary
Company Details
1st Matru Chhaya Ground Floor, M Karve Road Naupada Thane Maharashtra : 400602
stock-summary
Tel: 91-22-25390009/25438095
stock-summary
narendrainvestmentdelhi@gmail.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai